Table 6.
Variables | CHC HOMA-IR >4 20(40%) |
HCC HOMA-IR >4 26(52%) |
---|---|---|
Age | ||
>57 years | 13(65) | 17(65) |
Male gender: | 14(70) | 17 (65) |
Obese(>25 kg/m2) | 16 (80) | 17(65) |
LFT (Mean ± SD) | ||
ALT (>37 IU/L) | 18(90) | 24(92) |
AST (>40 IU/L) | 18(90) | 26(100) |
T. Bil (> 1 mg/dL) | 13(65) | 26(100) |
INR (> 1-) | 18(90) | 26(100) |
GGT (>50 IU/L) | 17(85) | 26(100) |
Biochemical tests | ||
Fasting glucose (>110 mg/dL) | 20(100) | 26(100) |
Fasting insulin (>6IU/L) | 20(100) | 26(100) |
HbA1c (>7%) | 19(95) | 25(96) |
Cholesterol (>200 mg/dL) | 14(70) | 15(58) |
TG(> 150 mg/dL) | 20(100) | 25(96) |
Tumor marker | ||
Serum AFP (>10 ng/mL) | 20(100) | 26(100) |
HCV RNA (viral load) N(%) | ||
Moderate | 12(60) | 19(73) |
High | 7(35) | 7(27) |
Stage of Fibrosis | ||
III+IV | 19(95) | 26(100) |